Cargando…

Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting

BACKGROUND AND AIMS: While a minority of inflammatory bowel disease (IBD) patients receives biologics in Germany, little is known about therapeutic needs of patients receiving non-biologic therapies. This study aimed to identify indicators of active disease/steroid dependency in patients with modera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bokemeyer, B., Ghiani, M., Fuchs, A., Deiters, B., Hardtstock, F., Brandes, A., Knop, J., Orzechowski, H. D., Wilke, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340655/ https://www.ncbi.nlm.nih.gov/pubmed/32424526 http://dx.doi.org/10.1007/s00384-020-03588-w

Ejemplares similares

Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
por: Knapp, Rachel K., et al.
Publicado: (2021)

Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data
por: Zhuleku, Evi, et al.
Publicado: (2022)

Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
por: Hardtstock, Fränce, et al.
Publicado: (2020)

Burden of disease among patients with prevalent Crohn’s disease: results from a large German sickness fund
por: Zhuleku, Evi, et al.
Publicado: (2023)

Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review
por: Helwig, Ulf, et al.
Publicado: (2020)

Poststroke epilepsy incidence, risk factors and treatment: German claims analysis
por: Hardtstock, Fränce, et al.
Publicado: (2021)

P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data
por: Pacis, S, et al.
Publicado: (2022)

Indications and diagnostic yield of small-bowel capsule endoscopy in a real-world setting
por: Kharazmi, André Artan, et al.
Publicado: (2020)

Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data
por: Müller, Sabrina, et al.
Publicado: (2021)

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis
por: Buhl, Roland, et al.
Publicado: (2022)

Use of Biologic Therapies in the Treatment of Asthma – A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation
por: Hardtstock, Fraence, et al.
Publicado: (2022)

Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events
por: Hardtstock, Fränce, et al.
Publicado: (2021)

Pharmacologic therapy for inflammatory bowel disease refractory to steroids
por: Martínez-Montiel, MP, et al.
Publicado: (2015)

Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease
por: Gress, Kyle, et al.
Publicado: (2020)

Real-world evidence for steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease
por: Folkerts, Kerstin, et al.
Publicado: (2022)

Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
por: Wilke, Thomas, et al.
Publicado: (2022)

P64 Evaluating the Impact of the COVID-19 Pandemic on Mortality after Myocardial Infarctions Hospitalization in Germany
por: Krieger, J, et al.
Publicado: (2022)

Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review
por: Terjung, Birgit, et al.
Publicado: (2020)

P40 REAL-WORLD TREATMENT PATTERNS OF PATIENTS INITIATING THIRD-LINE THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA IN EUROPE
por: Lehne, M., et al.
Publicado: (2023)

Ustekinumab in Crohn's disease: Real‐world outcomes from the Sicilian network for inflammatory bowel diseases
por: Viola, Anna, et al.
Publicado: (2021)

First German-Austrian case-mix comparison with real life data
por: Wilke, Michael, et al.
Publicado: (2008)

Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data
por: Bokemeyer, Bernd, et al.
Publicado: (2022)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
por: Wilke, Thomas, et al.
Publicado: (2019)

IRGM Variants and Susceptibility to Inflammatory Bowel Disease in the German Population
por: Glas, Jürgen, et al.
Publicado: (2013)

POSB189 Mental Health in COVID Times: A Quasi-Experimental Analysis of the Impact of Lockdown Measures on Mental Healthcare Use in Germany
por: Ghiani, M, et al.
Publicado: (2022)

Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
por: Zaltman, Cyrla, et al.
Publicado: (2021)

Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil
por: Sassaki, Ligia Yukie, et al.
Publicado: (2021)

The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
por: Abej, Esmail, et al.
Publicado: (2016)

Informed consent in inflammatory bowel disease: a necessity in real-world clinical practice
por: Kyriakos, Nikolaos, et al.
Publicado: (2021)

Real-World Use of Azathioprine Metabolites Changes Clinical Management of Inflammatory Bowel Disease
por: Wilson, Laura, et al.
Publicado: (2020)

Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data
por: Goss Sawhney, Tia, et al.
Publicado: (2023)

P33 Evaluating the Impact of the COVID-19 Pandemic on the Diagnosis and Staging of New Breast Cancer Cases: A Retrospective Analysis of Medical Chart Data from the United States
por: Knapp, R., et al.
Publicado: (2022)

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease
por: Klein, Amir, et al.
Publicado: (2010)

Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims data
por: Warkentin, Lisette, et al.
Publicado: (2023)

Using multiple imputation of real-world data to estimate clinical remission in pediatric inflammatory bowel disease
por: Zhang, Nanhua, et al.
Publicado: (2023)

Small bowel diaphragm disease--strictures associated with non-steroidal anti-inflammatory drugs.
por: McCune, K. H., et al.
Publicado: (1992)

Incidence, Prevalence, Hospitalization Rates, and Treatment Patterns in Myasthenia Gravis: A 10-Year Real-World Data Analysis of German Claims Data
por: Wartmann, Hannes, et al.
Publicado: (2023)

Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
por: Mevius, Antje, et al.
Publicado: (2022)

Quality indicators in inflammatory bowel disease
por: Berry, Sameer K., et al.
Publicado: (2018)

Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
por: Wei, Cong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nr4qpdhvk3b1sf258comdc4d69